[go: up one dir, main page]

CN116850346A - Polydopamine and magnesium ion modified silk scaffold material and preparation method and application thereof - Google Patents

Polydopamine and magnesium ion modified silk scaffold material and preparation method and application thereof Download PDF

Info

Publication number
CN116850346A
CN116850346A CN202310897050.3A CN202310897050A CN116850346A CN 116850346 A CN116850346 A CN 116850346A CN 202310897050 A CN202310897050 A CN 202310897050A CN 116850346 A CN116850346 A CN 116850346A
Authority
CN
China
Prior art keywords
polydopamine
silk
silk fiber
hot
base material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310897050.3A
Other languages
Chinese (zh)
Inventor
代方银
程岚
许翔
王艺
童晓玲
丁鑫
刘祖兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southwest University
Original Assignee
Southwest University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southwest University filed Critical Southwest University
Priority to CN202310897050.3A priority Critical patent/CN116850346A/en
Publication of CN116850346A publication Critical patent/CN116850346A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/306Other specific inorganic materials not covered by A61L27/303 - A61L27/32
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606Coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明提供了一种聚多巴胺和镁离子改性的蚕丝支架材料及其制备方法和应用,属于骨修复材料技术领域。本发明以热压后的平板丝作为基底材料,省去了传统技术的削茧、脱胶等一系列繁琐步骤,操作简单,成本低廉,工艺环保,且热压平板丝后,蚕丝支架材料的力学性能大幅度提升;本发明使用三元溶液对蚕丝纤维基材进行微处理,使得基底材料表面粗糙度增加,利于细胞后续的黏附生长,再通过多巴胺自聚合形成的聚多巴胺接枝在材料表面,提高蚕丝纤维基材的亲水性和生物相容性;镁离子能够取代聚多巴胺儿茶酚结构中的羟基,利用聚多巴胺的接枝作用,将镁离子接枝于蚕丝纤维基材表面,从而在调节巨噬细胞极化、促血管生成和促骨再生方面发挥优良效果。

The invention provides a polydopamine and magnesium ion-modified silk scaffold material and its preparation method and application, and belongs to the technical field of bone repair materials. The invention uses hot-pressed flat silk as the base material, eliminating a series of tedious steps such as cocoon cutting and degumming in traditional techniques. It is simple to operate, low-cost, and the process is environmentally friendly. After hot-pressing the flat silk, the mechanics of the silk support material are improved. The performance is greatly improved; the present invention uses a ternary solution to micro-process the silk fiber base material to increase the surface roughness of the base material, which is beneficial to the subsequent adhesion and growth of cells, and then polydopamine formed by dopamine self-polymerization is grafted on the surface of the material. Improve the hydrophilicity and biocompatibility of the silk fiber base material; magnesium ions can replace the hydroxyl groups in the catechol structure of polydopamine, and use the grafting effect of polydopamine to graft the magnesium ions onto the surface of the silk fiber base material, thereby It has excellent effects in regulating macrophage polarization, promoting angiogenesis and promoting bone regeneration.

Description

一种聚多巴胺和镁离子改性的蚕丝支架材料及其制备方法和 应用A polydopamine and magnesium ion modified silk scaffold material and its preparation method and application

技术领域Technical field

本发明涉及骨修复材料技术领域,特别涉及一种聚多巴胺和镁离子改性的蚕丝支架材料及其制备方法和应用。The present invention relates to the technical field of bone repair materials, and in particular to a polydopamine and magnesium ion-modified silk scaffold material and its preparation method and application.

背景技术Background technique

在世界范围内,意外和疾病导致骨损伤的发生率正在增加。此外,随着世界人口的持续增长,老龄人口的比例持续增加,这导致骨科疾病的发病率也大幅提高,随之对骨修复的需求以及难度也大量增加。目前用于骨修复的生物材料分为以下几种:医用生物陶瓷、医用高分子材料、医用复合材料、纳米人工骨。The incidence of bone injuries from accidents and illness is increasing worldwide. In addition, as the world's population continues to grow, the proportion of the elderly population continues to increase, which has led to a significant increase in the incidence of orthopedic diseases, and subsequently the demand and difficulty of bone repair have also increased significantly. Biomaterials currently used for bone repair are divided into the following categories: medical bioceramics, medical polymer materials, medical composite materials, and nano-artificial bone.

医用生物陶瓷材料主要是利用羟基磷灰石(HAP)进行骨组织的修复,因其组成性质与生物硬组织的HAP极为相似,同时具有良好的生物相容性,可与自然骨形成强的骨键合,利于后续的矿化以及骨组织再生;但其强度较低,不宜作为人体承力部件。Medical bioceramic materials mainly use hydroxyapatite (HAP) to repair bone tissue. Its composition and properties are very similar to HAP in biological hard tissue. It also has good biocompatibility and can form a strong bone with natural bone. Bonding is beneficial to subsequent mineralization and bone tissue regeneration; however, its strength is low and it is not suitable as a load-bearing component of the human body.

高分子聚合物已被广泛用作骨修复材料,其中可降解聚乳酸(PLA)用于口腔外科,聚甲基丙烯酸甲酯(PMMA)骨水泥用于骨填充,聚乙醇酸(PGA)作为可吸收螺钉用于骨固定,生物降解材料制作的接骨材料,其弹性模量较金属更接近骨组织的弹性模量,且随着骨折的愈合,材料逐渐在体内降解,不需二次手术取出。High molecular polymers have been widely used as bone repair materials, among which degradable polylactic acid (PLA) is used in oral surgery, polymethylmethacrylate (PMMA) bone cement is used for bone filling, and polyglycolic acid (PGA) is used as a biodegradable bone repair material. Absorbable screws are used for bone fixation. The elastic modulus of bone grafting materials made of biodegradable materials is closer to that of bone tissue than metals. As the fracture heals, the material gradually degrades in the body, eliminating the need for secondary surgery to remove it.

蚕丝作为天然高分子生物材料,由于其许多独特的性能,包括卓越的生物相容性、生物降解性、机械行为和易加工性,在骨组织工程应用中建立了良好的声誉。通过对丝素蛋白不同的加工工艺,可以将丝素蛋白加工成丝素多孔海绵、丝素水凝胶、丝素基支架、丝素纳米粒等各种生物材料。然而,传统的应用蚕丝蛋白需要对蚕丝进行一系列的加工,工序复杂、成本增加,容易对环境造成污染,因此难以实现广泛的应用。Silk, as a natural polymer biomaterial, has established a good reputation in bone tissue engineering applications due to its many unique properties, including excellent biocompatibility, biodegradability, mechanical behavior, and ease of processing. Through different processing techniques of silk fibroin, silk fibroin can be processed into various biological materials such as silk fibroin porous sponges, silk fibroin hydrogels, silk fibroin-based scaffolds, and silk fibroin nanoparticles. However, the traditional application of silk protein requires a series of processing of silk. The process is complex, the cost is increased, and it is easy to pollute the environment, so it is difficult to achieve widespread application.

发明内容Contents of the invention

有鉴于此,本发明目的在于提供一种聚多巴胺和镁离子改性的蚕丝支架材料及其制备方法和应用。本发明提供的制备方法操作简单,成本低廉,工艺环保,所得蚕丝支架材料具有优异的机械性能和生物相容性、可调节巨噬细胞极化、促血管生成和促骨再生的效果。In view of this, the object of the present invention is to provide a polydopamine and magnesium ion-modified silk scaffold material and its preparation method and application. The preparation method provided by the invention is simple to operate, low in cost, and the process is environmentally friendly. The obtained silk scaffold material has excellent mechanical properties and biocompatibility, and can regulate macrophage polarization, promote angiogenesis, and promote bone regeneration.

为了实现上述发明目的,本发明提供以下技术方案:In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

本发明提供了一种聚多巴胺和镁离子改性的蚕丝支架材料的制备方法,包括以下步骤:The invention provides a method for preparing a polydopamine- and magnesium-ion-modified silk scaffold material, which includes the following steps:

(1)对堆叠的多层平板丝进行热压,得到热压蚕丝纤维基材;(1) Hot-press the stacked multi-layer flat silk to obtain a hot-pressed silk fiber base material;

(2)将所述热压蚕丝纤维基材浸泡于三元溶液中,取出后冷冻干燥,得到预处理蚕丝纤维基材;所述三元溶液包括CaCl2、乙醇和水;(2) Soak the hot-pressed silk fiber base material in a ternary solution, take it out and freeze-dry it to obtain a pretreated silk fiber base material; the ternary solution includes CaCl 2 , ethanol and water;

(3)将所述预处理蚕丝纤维基材浸泡于含有镁离子的聚多巴胺溶液中,进行改性,得到聚多巴胺和镁离子改性的蚕丝支架材料。(3) The pretreated silk fiber base material is soaked in a polydopamine solution containing magnesium ions and modified to obtain a polydopamine- and magnesium ion-modified silk scaffold material.

优选的,所述多层平板丝的堆叠厚度为0.1~30cm;Preferably, the stacking thickness of the multi-layer flat wire is 0.1-30cm;

所述热压的温度为80~130℃,热压压强为10~500MPa,保温保压时间为5~180min。The hot pressing temperature is 80-130°C, the hot-pressing pressure is 10-500MPa, and the heat and pressure holding time is 5-180 minutes.

优选的,所述三元溶液中,CaCl2、乙醇和水的摩尔比为0.9~1:2:6.5~8。Preferably, the molar ratio of CaCl 2 , ethanol and water in the ternary solution is 0.9-1:2:6.5-8.

优选的,所述步骤(2)中浸泡的温度为60~100℃,时间为5~15min。Preferably, the soaking temperature in step (2) is 60-100°C and the soaking time is 5-15 minutes.

优选的,所述含有镁离子的聚多巴胺溶液的制备方法,包括以下步骤:Preferably, the preparation method of the polydopamine solution containing magnesium ions includes the following steps:

将盐酸多巴胺与Tris-HCl溶液混合,进行自聚合反应,得到聚多巴胺溶液;Mix dopamine hydrochloride and Tris-HCl solution to perform a self-polymerization reaction to obtain a polydopamine solution;

将可溶性镁盐与所述聚多巴胺溶液混合,得到含有镁离子的聚多巴胺溶液。The soluble magnesium salt is mixed with the polydopamine solution to obtain a polydopamine solution containing magnesium ions.

优选的,所述Tris-HCl溶液的浓度为10mM,pH值为8.5。Preferably, the concentration of the Tris-HCl solution is 10mM and the pH value is 8.5.

优选的,所述含有镁离子的聚多巴胺溶液中,镁离子的浓度为0.00005~0.01mol/L,聚多巴胺的浓度为2~4mg/mL。Preferably, in the polydopamine solution containing magnesium ions, the concentration of magnesium ions is 0.00005-0.01 mol/L, and the concentration of polydopamine is 2-4 mg/mL.

优选的,所述步骤(3)中改性的时间为12~24h。Preferably, the modification time in step (3) is 12 to 24 hours.

本发明提供了上述制备方法制备得到的聚多巴胺和镁离子改性的蚕丝支架材料,包括热压的蚕丝纤维基材和修饰在所述蚕丝纤维基材表面的聚多巴胺和镁离子。The invention provides a polydopamine- and magnesium-ion-modified silk scaffold material prepared by the above preparation method, including a hot-pressed silk fiber base material and polydopamine and magnesium ions modified on the surface of the silk fiber base material.

本发明提供了上述聚多巴胺和镁离子改性的蚕丝支架材料在制备骨修复材料中的应用。The invention provides the application of the above-mentioned polydopamine and magnesium ion-modified silk scaffold materials in the preparation of bone repair materials.

本发明提供了一种聚多巴胺和镁离子改性的蚕丝支架材料的制备方法,包括以下步骤:(1)对堆叠的多层平板丝进行热压,得到热压蚕丝纤维基材;(2)将所述热压蚕丝纤维基材浸泡于三元溶液中,取出后冷冻干燥,得到预处理蚕丝纤维基材;所述三元溶液包括CaCl2、乙醇和水;(3)将所述预处理蚕丝纤维基材浸泡于含有镁离子的聚多巴胺溶液中,进行改性,得到聚多巴胺和镁离子改性的蚕丝支架材料。本发明以热压后的平板丝作为基底材料,省去了传统技术的削茧、脱胶等一系列繁琐步骤,操作简单,成本低廉,工艺环保,且热压平板丝后,蚕丝支架材料的力学性能大幅度提升;本发明使用三元溶液对蚕丝纤维基材进行微处理,使得基底材料表面粗糙度增加,利于细胞后续的黏附生长,再通过多巴胺自聚合形成的聚多巴胺依靠本身的类粘性蛋白结构接枝在材料表面,提高蚕丝纤维基材的亲水性,并使其拥有更优异的生物相容性;镁离子能够取代聚多巴胺儿茶酚结构中的羟基,本发明利用聚多巴胺的接枝作用,将镁离子接枝于蚕丝纤维基材表面,从而在调节巨噬细胞极化、促血管生成和促骨再生方面发挥优良效果。Mc3t3-e1细胞与巨噬细胞增殖实验表明交联聚多巴胺后蚕丝纤维基材的生物相容性提高;极化实验表明本发明聚多巴胺和镁离子改性的蚕丝支架材料能够促进巨噬细胞的表型转变;茜素红与碱性磷酸酶染色实验表明本发明聚多巴胺和镁离子改性的蚕丝支架材料拥有优秀的成骨能力。The invention provides a method for preparing a polydopamine- and magnesium-ion-modified silk scaffold material, which includes the following steps: (1) hot-pressing stacked multi-layer flat-plate silks to obtain a hot-pressed silk fiber base material; (2) The hot-pressed silk fiber base material is soaked in a ternary solution, taken out and then freeze-dried to obtain a pretreated silk fiber base material; the ternary solution includes CaCl 2 , ethanol and water; (3) the pretreatment The silk fiber base material is soaked in a polydopamine solution containing magnesium ions and modified to obtain a polydopamine- and magnesium ion-modified silk scaffold material. The invention uses hot-pressed flat silk as the base material, eliminating a series of tedious steps such as cocoon cutting and degumming in traditional techniques. It is simple to operate, low-cost, and the process is environmentally friendly. After hot-pressing the flat silk, the mechanics of the silk support material are improved. The performance is greatly improved; the present invention uses a ternary solution to micro-process the silk fiber base material to increase the surface roughness of the base material, which is beneficial to the subsequent adhesion and growth of cells. The polydopamine formed by dopamine self-polymerization relies on its own sticky protein The structure is grafted on the surface of the material to improve the hydrophilicity of the silk fiber base material and make it have better biocompatibility; magnesium ions can replace the hydroxyl groups in the catechol structure of polydopamine. The present invention utilizes the grafting of polydopamine. The magnesium ions are grafted onto the surface of the silk fiber substrate through dendritic effects, thereby exerting excellent effects in regulating macrophage polarization, promoting angiogenesis and promoting bone regeneration. The Mc3t3-e1 cell and macrophage proliferation experiment shows that the biocompatibility of the silk fiber substrate is improved after cross-linking polydopamine; the polarization experiment shows that the polydopamine and magnesium ion-modified silk scaffold material of the present invention can promote the growth of macrophages. Phenotypic transformation; Alizarin red and alkaline phosphatase staining experiments show that the polydopamine and magnesium ion-modified silk scaffold material of the present invention has excellent osteogenic ability.

附图说明Description of the drawings

图1为不同处理的热压蚕丝纤维基材的实物图;Figure 1 is a physical picture of hot-pressed silk fiber substrates with different treatments;

图2为不同处理的热压蚕丝纤维基材的红外光谱图;Figure 2 shows the infrared spectra of hot-pressed silk fiber substrates with different treatments;

图3为不同处理的热压蚕丝纤维基材的接触角;Figure 3 shows the contact angles of hot-pressed silk fiber substrates with different treatments;

图4为不同处理的热压蚕丝纤维基材的应力-应变变化图;Figure 4 shows the stress-strain change diagram of hot-pressed silk fiber substrates with different treatments;

图5为不同处理的热压蚕丝纤维基材的EDS元素分析图;Figure 5 shows the EDS elemental analysis diagram of hot-pressed silk fiber substrates with different treatments;

图6为不同处理的热压蚕丝纤维基材的镁元素定量图;Figure 6 is a quantitative chart of magnesium elements in hot-pressed silk fiber substrates with different treatments;

图7为Mc3t3-e1细胞增殖结果;Figure 7 shows the proliferation results of Mc3t3-e1 cells;

图8为Raw细胞增殖结果;Figure 8 shows the Raw cell proliferation results;

图9为巨噬细胞极化结果;Figure 9 shows the results of macrophage polarization;

图10为茜素红与碱性磷酸酶染色实验结果;Figure 10 shows the experimental results of alizarin red and alkaline phosphatase staining;

图11为Micro-CT三维重建图像结果;Figure 11 shows the Micro-CT three-dimensional reconstructed image results;

图12为术后6周小鼠骨体积分数定量结果。Figure 12 shows the quantitative results of mouse bone volume fraction 6 weeks after surgery.

具体实施方式Detailed ways

本发明提供了一种聚多巴胺和镁离子改性的蚕丝支架材料的制备方法,包括以下步骤:The invention provides a method for preparing a polydopamine- and magnesium-ion-modified silk scaffold material, which includes the following steps:

(1)对堆叠的多层平板丝进行热压,得到热压蚕丝纤维基材;(1) Hot-press the stacked multi-layer flat silk to obtain a hot-pressed silk fiber base material;

(2)将所述热压蚕丝纤维基材浸泡于三元溶液中,取出后冷冻干燥,得到预处理蚕丝纤维基材;所述三元溶液包括CaCl2、乙醇和水;(2) Soak the hot-pressed silk fiber base material in a ternary solution, take it out and freeze-dry it to obtain a pretreated silk fiber base material; the ternary solution includes CaCl 2 , ethanol and water;

(3)将所述预处理蚕丝纤维基材浸泡于含有镁离子的聚多巴胺溶液中,进行改性,得到聚多巴胺和镁离子改性的蚕丝支架材料。(3) The pretreated silk fiber base material is soaked in a polydopamine solution containing magnesium ions and modified to obtain a polydopamine- and magnesium ion-modified silk scaffold material.

本发明对堆叠的多层平板丝进行热压,得到热压蚕丝纤维基材。在本发明中,所述平板丝优选为五龄上簇熟蚕于二维的吐丝床平面上吐丝得到的平板丝。在本发明中,所述平板丝的克重优选为2~3g。In the present invention, stacked multi-layer flat silks are hot-pressed to obtain a hot-pressed silk fiber base material. In the present invention, the flat silk is preferably a flat silk produced by five-instar mature silkworms spinning on a two-dimensional spinning bed plane. In the present invention, the weight of the flat yarn is preferably 2 to 3 g.

在本发明中,所述平板丝的堆叠层数优选为1~300层,更优选为10~200层,更优选为50~100层。在本发明中,所述多层平板丝的堆叠厚度优选为0.1~30cm,更优选为1~15cm,进一步优选为5~10cm。In the present invention, the number of stacked layers of the flat wire is preferably 1 to 300 layers, more preferably 10 to 200 layers, and more preferably 50 to 100 layers. In the present invention, the stacking thickness of the multi-layer flat wire is preferably 0.1 to 30 cm, more preferably 1 to 15 cm, and even more preferably 5 to 10 cm.

本发明优选使用热压机进行所述热压;在本发明中,所述热压的温度优选为80~130℃,更优选为100~120℃;热压压强优选为10~500MPa,更优选为50~300MPa,进一步优选为100~200MPa;保温保压时间优选为5~180min,更优选为10~150min,进一步优选为30~100min。本发明通过所述热压,使蚕丝纤维基材热塑成型。In the present invention, a hot press is preferably used to perform the hot pressing; in the present invention, the temperature of the hot pressing is preferably 80 to 130°C, more preferably 100 to 120°C; the hot pressing pressure is preferably 10 to 500MPa, more preferably It is 50-300MPa, more preferably 100-200MPa; the temperature and pressure holding time is preferably 5-180min, more preferably 10-150min, further preferably 30-100min. In the present invention, the silk fiber base material is thermoplastically formed through the hot pressing.

得到所述热压蚕丝纤维基材后,本发明将所述热压蚕丝纤维基材浸泡于三元溶液中,取出后冷冻干燥,得到预处理蚕丝纤维基材;所述三元溶液包括CaCl2、乙醇和水。在本发明中,所述三元溶液中,CaCl2、乙醇和水的摩尔比优选为0.9~1:2:6.5~8,进一步优选为1:2:8、1:2:7、1:2:6.5或0.9:2:8。After obtaining the hot-pressed silk fiber base material, the present invention soaks the hot-pressed silk fiber base material in a ternary solution, takes it out and freeze-dries it to obtain a pretreated silk fiber base material; the ternary solution includes CaCl 2 , ethanol and water. In the present invention, in the ternary solution, the molar ratio of CaCl 2 , ethanol and water is preferably 0.9-1:2:6.5-8, and more preferably 1:2:8, 1:2:7, 1: 2:6.5 or 0.9:2:8.

在本发明中,所述浸泡的温度优选为60~100℃,更优选为70~80℃;时间优选为5~15min,更优选为10min。本发明通过适宜的三元溶液微处理材料表面时间,使得材料表面部分丝胶溶解在三元溶液中,造成材料表面呈凹凸不规状,这一定程度上增加热压蚕丝纤维基材表面的粗糙度。In the present invention, the soaking temperature is preferably 60-100°C, more preferably 70-80°C; the soaking time is preferably 5-15 min, more preferably 10 min. The present invention uses a suitable ternary solution to micro-treat the surface of the material for a period of time, so that part of the sericin on the surface of the material is dissolved in the ternary solution, causing the material surface to be uneven and irregular, which to a certain extent increases the roughness of the surface of the hot-pressed silk fiber base material. Spend.

在本发明中,所述冷冻干燥优选包括依次进行的冷冻和真空冷冻干燥。在本发明中,所述冷冻优选在冰箱中进行,所述冷冻的温度优选为-40℃~-100℃,时间优选为12h。本发明对所述真空冷冻干燥的具体操作方式没有特殊的要求,使用本领域技术人员熟知的真空冷冻干燥方式即可。In the present invention, the freeze-drying preferably includes sequential freezing and vacuum freeze-drying. In the present invention, the freezing is preferably performed in a refrigerator, the freezing temperature is preferably -40°C to -100°C, and the freezing time is preferably 12 hours. The present invention has no special requirements for the specific operation mode of the vacuum freeze-drying, and it is enough to use the vacuum freeze-drying mode well known to those skilled in the art.

得到所述预处理蚕丝纤维基材后,本发明将所述预处理蚕丝纤维基材浸泡于含有镁离子的聚多巴胺溶液中,进行改性,得到聚多巴胺和镁离子改性的蚕丝支架材料。在本发明中,所述含有镁离子的聚多巴胺溶液的制备方法,优选包括以下步骤:After obtaining the pretreated silk fiber base material, the present invention soaks the pretreated silk fiber base material in a polydopamine solution containing magnesium ions and performs modification to obtain a polydopamine and magnesium ion modified silk scaffold material. In the present invention, the preparation method of the polydopamine solution containing magnesium ions preferably includes the following steps:

将盐酸多巴胺与Tris-HCl溶液混合,进行自聚合反应,得到聚多巴胺溶液;Mix dopamine hydrochloride and Tris-HCl solution to perform a self-polymerization reaction to obtain a polydopamine solution;

将可溶性镁盐与所述聚多巴胺溶液混合,得到含有镁离子的聚多巴胺溶液。The soluble magnesium salt is mixed with the polydopamine solution to obtain a polydopamine solution containing magnesium ions.

在本发明中,所述Tris-HCl溶液的浓度优选为10mM,pH值优选为8.5。在本发明中,所述自聚合反应的温度优选为室温,时间优选为12~24h,更优选为16~20h。In the present invention, the concentration of the Tris-HCl solution is preferably 10 mM, and the pH value is preferably 8.5. In the present invention, the temperature of the self-polymerization reaction is preferably room temperature, and the time is preferably 12 to 24 hours, and more preferably 16 to 20 hours.

在本发明中,所述聚多巴胺溶液中,聚多巴胺的浓度优选为2~4mg/mL,更优选为3mg/mL。In the present invention, the concentration of polydopamine in the polydopamine solution is preferably 2 to 4 mg/mL, and more preferably 3 mg/mL.

在本发明中,所述可溶性镁盐优选为MgSO4,所述含有镁离子的聚多巴胺溶液中,镁离子的浓度优选为0.00005~0.01mol/L,更优选为0.0001~0.0004mol/L。In the present invention, the soluble magnesium salt is preferably MgSO 4 , and the concentration of magnesium ions in the polydopamine solution containing magnesium ions is preferably 0.00005 to 0.01 mol/L, and more preferably 0.0001 to 0.0004 mol/L.

在本发明中,所述预处理蚕丝纤维基材浸泡于含有镁离子的聚多巴胺溶液中的顺序优选为:先将预处理蚕丝纤维基材浸泡于聚多巴胺溶液中,再加入可溶性镁盐。In the present invention, the order in which the pretreated silk fiber base material is soaked in the polydopamine solution containing magnesium ions is preferably: first soak the pretreated silk fiber base material in the polydopamine solution, and then add soluble magnesium salt.

在本发明中,所述改性的温度优选为室温,时间优选为12~24h,更优选为16~20h。在本发明中,所述改性的过程中,聚多巴胺接枝在预处理蚕丝纤维基材表面,镁离子取代多巴胺儿茶酚结构中的羟基,实现蚕丝纤维基材表面镁离子的修饰。In the present invention, the temperature of the modification is preferably room temperature, and the time is preferably 12 to 24 hours, and more preferably 16 to 20 hours. In the present invention, during the modification process, polydopamine is grafted on the surface of the pretreated silk fiber base material, and magnesium ions replace the hydroxyl groups in the catechol structure of dopamine, thereby realizing the modification of magnesium ions on the surface of the silk fiber base material.

所述改性后,本发明优选对聚多巴胺和镁离子改性的蚕丝支架材料进行洗涤和干燥。在本发明中,所述洗涤优选为水洗,所述干燥优选为自然风干干燥。After the modification, in the present invention, the polydopamine and magnesium ion-modified silk scaffold material is preferably washed and dried. In the present invention, the washing is preferably water washing, and the drying is preferably natural air drying.

本发明提供了上述制备方法制备得到的聚多巴胺和镁离子改性的蚕丝支架材料,包括热压的蚕丝纤维基材和修饰在所述蚕丝纤维基材表面的聚多巴胺和镁离子。The invention provides a polydopamine- and magnesium-ion-modified silk scaffold material prepared by the above preparation method, including a hot-pressed silk fiber base material and polydopamine and magnesium ions modified on the surface of the silk fiber base material.

本发明提供了上述聚多巴胺和镁离子改性的蚕丝支架材料在制备骨修复材料中的应用。本发明提供的聚多巴胺和镁离子改性的蚕丝支架材料具有优异的机械性能和生物相容性、可调节巨噬细胞极化、促血管生成和促骨再生的效果,可作为不同部位骨缺损的修复支架材料。The invention provides the application of the above-mentioned polydopamine and magnesium ion-modified silk scaffold materials in the preparation of bone repair materials. The polydopamine and magnesium ion-modified silk scaffold material provided by the invention has excellent mechanical properties and biocompatibility, can regulate macrophage polarization, promote angiogenesis and promote bone regeneration, and can be used as a treatment for bone defects in different parts of the body. Restorative scaffold materials.

下面结合实施例对本发明提供的聚多巴胺和镁离子改性的蚕丝支架材料及其制备方法和应用进行详细的说明,但是不能把它们理解为对本发明保护范围的限定。The polydopamine- and magnesium ion-modified silk scaffold material provided by the present invention and its preparation method and application will be described in detail below with reference to the examples, but they should not be understood as limiting the scope of the present invention.

实施例1Example 1

将一定数量的五龄上簇熟蚕置于二维的吐丝床平面上进行吐丝,获得0.1~0.3cm的平板丝,将获得的平板丝堆叠成厚度为2~4层的多层平板丝,利用热压机将多层平板丝热塑成型,其中热压的温度为105℃,时间为1h,压力为100MPa,形成热压蚕丝纤维基材。A certain number of fifth-instar mature silkworms are placed on a two-dimensional spinning bed plane to spin silk to obtain flat silk of 0.1 to 0.3 cm. The flat silk obtained is stacked into a multi-layered flat plate with a thickness of 2 to 4 layers. Silk, use a hot press to thermoform multiple layers of flat silk. The hot pressing temperature is 105°C, the time is 1 hour, and the pressure is 100 MPa to form a hot pressed silk fiber base material.

将热压蚕丝纤维基材三元溶液中进行预处理,三元溶液中CaCl2:EtOH:H2O的摩尔比为1:2:8,浸泡的温度为80℃,时间为10min。将预处理后的热压蚕丝纤维基材放入冰箱中冷冻,冷冻温度为-80℃,时间为12h,随后进行真空冷冻干燥处理,形成表面处理后热压蚕丝纤维基材。The hot-pressed silk fiber substrate is pretreated in a ternary solution. The molar ratio of CaCl 2 :EtOH:H 2 O in the ternary solution is 1:2:8. The soaking temperature is 80°C and the time is 10 minutes. The pretreated hot-pressed silk fiber base material is placed in a refrigerator and frozen at a freezing temperature of -80°C for 12 hours, and then vacuum freeze-dried to form a surface-treated hot-pressed silk fiber base material.

使用10mL Tris-HCl缓冲液(10mM,pH=8.5)作为溶剂溶解20mg盐酸多巴胺,得到聚多巴胺溶液;将表面处理后热压蚕丝纤维基材浸泡于聚多巴胺溶液中,加入MgSO4,控制MgSO4在聚多巴胺溶液中的浓度为0.00005mol/L,24h后取出材料,去离子水清洗三次后,形成聚多巴胺和镁离子改性的蚕丝支架材料,记为TH-PDA@Mg1。Use 10mL Tris-HCl buffer (10mM, pH=8.5) as the solvent to dissolve 20mg of dopamine hydrochloride to obtain a polydopamine solution; soak the surface-treated hot-pressed silk fiber substrate in the polydopamine solution, add MgSO 4 and control MgSO 4 The concentration in the polydopamine solution was 0.00005 mol/L. After 24 hours, the material was taken out and washed three times with deionized water to form a polydopamine and magnesium ion-modified silk scaffold material, recorded as TH-PDA@Mg1.

实施例2Example 2

与实施例1的区别在于,MgSO4在聚多巴胺溶液中的浓度为0.0001mol/L,记为TH-PDA@Mg2。The difference from Example 1 is that the concentration of MgSO 4 in the polydopamine solution is 0.0001 mol/L, which is recorded as TH-PDA@Mg2.

实施例3Example 3

与实施例1的区别在于,MgSO4在聚多巴胺溶液中的浓度为0.0002mol/L,记为TH-PDA@Mg3。The difference from Example 1 is that the concentration of MgSO 4 in the polydopamine solution is 0.0002 mol/L, which is recorded as TH-PDA@Mg3.

实施例4Example 4

与实施例1的区别在于,MgSO4在聚多巴胺溶液中的浓度为0.0004mol/L,记为TH-PDA@Mg4。The difference from Example 1 is that the concentration of MgSO 4 in the polydopamine solution is 0.0004 mol/L, which is recorded as TH-PDA@Mg4.

实施例5Example 5

与实施例1的区别在于,MgSO4在聚多巴胺溶液中的浓度为0.001mol/L,记为TH-PDA@Mg5。The difference from Example 1 is that the concentration of MgSO 4 in the polydopamine solution is 0.001 mol/L, which is recorded as TH-PDA@Mg5.

测试例1Test example 1

以下结构表征和性能测试中,HFSC代表为热压蚕丝纤维基材;THFSC代表为表面处理后热压蚕丝纤维基;TH-PDA代表为浸泡在聚多巴胺溶液后的表面处理热压蚕丝纤维基;TH-PDA@Mg1-5代表为不同镁离子浓度下浸泡在聚多巴胺溶液后的表面处理热压蚕丝纤维基。In the following structural characterization and performance tests, HFSC represents the hot-pressed silk fiber base; THFSC represents the hot-pressed silk fiber base after surface treatment; TH-PDA represents the surface-treated hot-pressed silk fiber base soaked in polydopamine solution; TH-PDA@Mg1-5 represents a surface-treated hot-pressed silk fiber base soaked in polydopamine solution at different magnesium ion concentrations.

不同处理的热压蚕丝纤维基材的实物图如图1所示,红外光谱图如图2所示。从实物图与红外光谱图中中可以观察到多巴胺成功自聚合成聚多巴胺且交联于蚕丝纤维基材表面。The physical pictures of hot-pressed silk fiber substrates with different treatments are shown in Figure 1, and the infrared spectra are shown in Figure 2. From the physical images and infrared spectra, it can be observed that dopamine successfully self-polymerized into polydopamine and was cross-linked on the surface of the silk fiber substrate.

不同处理的热压蚕丝纤维基材的接触角如图3所示,应力-应变变化图如图4所示。接触角与应力-应变表明聚多巴胺和镁离子改性的蚕丝纤维基材拥有更好的亲水性,利于细胞的黏附生长,同时相对于表面处理后热压蚕丝纤维力学性能也有一定的改善。The contact angles of hot-pressed silk fiber substrates with different treatments are shown in Figure 3, and the stress-strain change diagram is shown in Figure 4. The contact angle and stress-strain showed that the silk fiber substrate modified with polydopamine and magnesium ions has better hydrophilicity, which is conducive to the adhesion and growth of cells. At the same time, the mechanical properties of the hot-pressed silk fiber after surface treatment are also improved.

对不同处理的热压蚕丝纤维基材进行EDS测试,所得EDS元素分析图如图5所示,图5中红色表示碳元素、绿色表示氮元素、蓝色表示氧元素、黄色表明镁元素。不同处理的热压蚕丝纤维基材的镁元素定量图如图6所示。EDS tests were conducted on hot-pressed silk fiber substrates with different treatments. The obtained EDS elemental analysis chart is shown in Figure 5. In Figure 5, red represents carbon, green represents nitrogen, blue represents oxygen, and yellow represents magnesium. The quantitative graph of magnesium element of hot-pressed silk fiber substrates with different treatments is shown in Figure 6.

由图5和图6可以看出,蚕丝纤维基材表面成功利用聚多巴胺接枝镁离子且随着镁离子浓度的增加,其蚕丝纤维基材表面的镁离子也增加。It can be seen from Figures 5 and 6 that polydopamine was successfully used to graft magnesium ions on the surface of the silk fiber substrate, and as the concentration of magnesium ions increased, the magnesium ions on the surface of the silk fiber substrate also increased.

测试例2Mc3t3-e1细胞与巨噬细胞增殖实验Test Example 2 Mc3t3-e1 Cell and Macrophage Proliferation Experiment

本测试例所采用的Mc3t3-e1细胞购买自中国科学院典型培养物保藏委员会细胞库/中国科学院上海生命科学院细胞资源中心;RAW264.7细胞来源于本课题组。Mc3t3-e1用含有10%胎牛血清、1%青链霉素的α-MEM培养基在37℃5%CO2条件下培养,每3天更换一次培养基;RAW264.7细胞用含有10%胎牛血清、1%青链霉素的DMEM培养基在37℃5%CO2条件下培养,每3天更换一次培养基。将各组蚕丝纤维基材用75%酒精浸泡2~3h,PBS冲洗3~5次后,放置于紫外环境照射2~3h。将Mc3t3-e1细胞与RAW264.7以5×104Cell/孔的密度接种在48孔板中,24h后,将上述灭菌材料放置于孔板中与细胞在培养箱中培养。采用MTS法检测两者细胞的增值活力,在预定时间点(24h48h)取出细胞板,吸出培养基,用PBS缓慢冲洗,在每孔加入500μL MTS工作液后放置在细胞培养箱中避光孵育2h。最后,吸取100μL上清液至96孔板中,通过酶标仪检测490nm波长下的吸光度。将接种含有10%FBS培养基作为对照,其吸光度值用于确定细胞的100%存活率。所有实验组均设置三个生物学重复。结果以细胞活力表示:细胞活力(%)=(Ae-An)/(Ap-An)×100,式中Ap为阳性对照组的吸光度,An为阴性对照组的吸光度,Ae为实验组的吸光度。The Mc3t3-e1 cells used in this test example were purchased from the Cell Bank of the Type Culture Collection Committee of the Chinese Academy of Sciences/Cell Resource Center of the Shanghai Academy of Biological Sciences, Chinese Academy of Sciences; the RAW264.7 cells were from this research group. Mc3t3-e1 was cultured in α-MEM medium containing 10% fetal bovine serum and 1% penicillin-streptomycin at 37°C and 5% CO2 , and the medium was changed every 3 days; RAW264.7 cells were cultured in α-MEM medium containing 10% penicillin-streptomycin at 37°C and 5% CO2. DMEM culture medium with fetal bovine serum and 1% penicillin and streptomycin was cultured at 37°C and 5% CO2 , and the culture medium was replaced every 3 days. Soak the silk fiber substrates of each group in 75% alcohol for 2 to 3 hours, rinse with PBS 3 to 5 times, and then place them in a UV environment for 2 to 3 hours. Mc3t3-e1 cells and RAW264.7 were seeded in a 48-well plate at a density of 5×10 4 Cell/well. After 24 hours, the above-mentioned sterilized materials were placed in the well plate and the cells were cultured in an incubator. Use the MTS method to detect the proliferative activity of the two cells. Take out the cell plate at the predetermined time point (24h48h), aspirate the culture medium, rinse slowly with PBS, add 500 μL MTS working solution to each well and place it in a cell culture incubator to avoid light and incubate for 2h. . Finally, 100 μL of the supernatant was pipetted into a 96-well plate, and the absorbance at a wavelength of 490 nm was detected by a microplate reader. Medium containing 10% FBS was inoculated as a control, and its absorbance value was used to determine 100% viability of the cells. All experimental groups were set up with three biological replicates. The results are expressed as cell viability: Cell viability (%) = (A e -A n )/(A p -A n ) × 100, where A p is the absorbance of the positive control group, A n is the absorbance of the negative control group, A e is the absorbance of the experimental group.

Mc3t3-e1细胞增殖结果如图7所示,Raw细胞增殖结果如图8所示。结果表明,交联聚多巴胺后蚕丝纤维基材的生物相容性提高。The Mc3t3-e1 cell proliferation results are shown in Figure 7, and the Raw cell proliferation results are shown in Figure 8. The results show that the biocompatibility of silk fiber substrates is improved after cross-linking polydopamine.

测试例3巨噬细胞极化实验Test Example 3 Macrophage Polarization Experiment

巨噬细胞作为一种触发先天免疫反应的前体细胞类型,具有独特的功能和表型特征。巨噬细胞根据其功能和表面标记物可分为经典激活的M1表型和交替激活的M2表型。M1型巨噬细胞通常被认为是表达高水平的促炎细胞因子,如一氧化氮酶(iNOS)、血管内皮生长因子(VEGF)、白细胞介素IL-6、肿瘤坏死因子TNF-α等,诱导炎症浸润;M2型巨噬细胞通常具有抗炎分子的特征,如甘露糖受体MRC-1(也称CD206)、趋化因子、谷氨酰胺转氨酶2等。巨噬细胞聚集在植入部位,并与植入材料相黏附形成巨细胞,分泌各种化学成分来调控微环境,在组织再生中起着至关重要的作用。已有研究报道,生物材料诱导的M2型巨噬细胞极化利于骨损伤再生的快速修复。Macrophages, as a precursor cell type that triggers innate immune responses, have unique functional and phenotypic characteristics. Macrophages can be divided into classically activated M1 phenotypes and alternatively activated M2 phenotypes based on their functions and surface markers. M1 macrophages are generally considered to express high levels of pro-inflammatory cytokines, such as nitric oxide enzyme (iNOS), vascular endothelial growth factor (VEGF), interleukin IL-6, tumor necrosis factor TNF-α, etc., which induce Inflammatory infiltration; M2 macrophages usually have the characteristics of anti-inflammatory molecules, such as mannose receptor MRC-1 (also known as CD206), chemokines, glutamine transaminase 2, etc. Macrophages gather at the implantation site and adhere to the implanted material to form giant cells, which secrete various chemical components to regulate the microenvironment and play a vital role in tissue regeneration. Studies have reported that the polarization of M2 macrophages induced by biomaterials is beneficial to the rapid repair of bone injury regeneration.

本测试例通过将M0型巨噬细胞诱导成M1型,研究蚕丝纤维基材对M1型巨噬细胞向M2型转化的作用,具体实验步骤如下:(1)RAW267.4在培养瓶中培养至70~80%融合时,将细胞以5×104Cell/mL接种在十二孔板中,每孔设置三个平行孔。(2)12h后吸出培养基,用无菌PBS清洗3次,每孔加入500μL 0.5μg/mL的脂多糖LPS(DMEM配制)诱导12h,析出培养基,PBS清洗2~3次,加入1mL DMEM完全培养基并放入各组蚕丝纤维基材,孵育48h。弃去培养基,PBS清洗3次。(3)室温下,每孔加入500μL4%多聚甲醛孵育10min以固定细胞。吸去多聚甲醛,PBS清洗3次。(4)每孔加入500μL 0.1%Trixton-100室温下通透10min。除去通透剂,PBS清洗3次,每次5min。(5)每孔加入1mL 1%BSA溶液室温下孵育1h,封闭抗体的非特异性结合。(6)每孔加入500μL稀释一抗(M1型一抗为iNOS,M2型一抗为MRC-1)4℃孵育过夜。(7)吸出一抗,用PBS清洗细胞3次,每次5min。(8)每孔加入500μL稀释二抗(溶于含1%BSA的PBS中)37℃避光孵育2h。(9)吸出二抗,PBS避光清洗3次,每次5min。(10)每孔加入500μLDAPI染液,复染细胞核10min。(11)使用超高分辨率共聚焦显微镜观察荧光强度。This test example studies the effect of silk fiber substrate on the transformation of M1 macrophages into M2 macrophages by inducing M0 macrophages into M1 macrophages. The specific experimental steps are as follows: (1) RAW267.4 is cultured in a culture bottle until When 70 to 80% confluence, the cells were seeded in a twelve-well plate at 5×10 4 Cell/mL, and three parallel wells were set in each well. (2) After 12 hours, aspirate the culture medium, wash it 3 times with sterile PBS, add 500 μL 0.5 μg/mL lipopolysaccharide LPS (prepared in DMEM) to each well for induction for 12 hours, separate out the culture medium, wash it 2 to 3 times with PBS, and add 1 mL DMEM Complete culture medium was placed into each group of silk fiber substrates, and incubated for 48 hours. Discard the culture medium and wash 3 times with PBS. (3) At room temperature, add 500 μL of 4% paraformaldehyde to each well and incubate for 10 minutes to fix the cells. Aspirate the paraformaldehyde and wash 3 times with PBS. (4) Add 500 μL of 0.1% Trixton-100 to each well and permeabilize for 10 minutes at room temperature. Remove the permeabilizing agent and wash with PBS 3 times for 5 minutes each time. (5) Add 1 mL of 1% BSA solution to each well and incubate at room temperature for 1 hour to block non-specific binding of the antibody. (6) Add 500 μL of diluted primary antibody to each well (M1 type primary antibody is iNOS, M2 type primary antibody is MRC-1) and incubate overnight at 4°C. (7) Aspirate the primary antibody and wash the cells with PBS 3 times for 5 minutes each time. (8) Add 500 μL of diluted secondary antibody (dissolved in PBS containing 1% BSA) to each well and incubate for 2 hours at 37°C in the dark. (9) Aspirate the secondary antibody and wash 3 times with PBS in the dark, 5 minutes each time. (10) Add 500 μL DAPI dye solution to each well and counterstain cell nuclei for 10 min. (11) Use ultra-high-resolution confocal microscopy to observe fluorescence intensity.

巨噬细胞极化实验结果如图9所示。可以看出,与Control组相比,THFSC组红色荧光减弱,而TH-PDA组与TH-PDA@Mg2组红色荧光大幅度减弱;同时THFSC组绿色荧光增强,而TH-PDA组与TH-PDA@Mg2组绿色荧光大幅度增强。表明蚕丝纤维基材在三元溶液处理后,由于部分溶解丝胶,THFSC具有低免疫原性,能诱导巨噬细胞表型转化,同时加入了镁离子之后能够更有利于巨噬细胞的表型转化。The results of macrophage polarization experiments are shown in Figure 9. It can be seen that compared with the Control group, the red fluorescence of the THFSC group was weakened, while the red fluorescence of the TH-PDA group and TH-PDA@Mg2 group was greatly weakened; at the same time, the green fluorescence of the THFSC group was enhanced, while the TH-PDA group and TH-PDA group were significantly weakened. The green fluorescence of the @Mg2 group was greatly enhanced. It shows that after the silk fiber substrate is treated with the ternary solution, due to the partial dissolution of sericin, THFSC has low immunogenicity and can induce the phenotype transformation of macrophages. At the same time, the addition of magnesium ions can be more beneficial to the phenotype of macrophages. Transformation.

极化实验表明利用聚多巴胺接枝镁离子后的蚕丝纤维基材能够促进巨噬细胞的表型转变。Polarization experiments show that polydopamine-grafted silk fiber substrates with magnesium ions can promote the phenotypic transformation of macrophages.

测试例4茜素红与碱性磷酸酶染色实验Test Example 4 Alizarin Red and Alkaline Phosphatase Staining Experiment

碱性磷酸酶(ALP)是骨形成所必需的酶,是成骨分化和功能成熟的早期标志,为了评估各组蚕丝纤维基材对Mc3t3-e1成骨分化的影响,采用碱性磷酸酶染色法测定其表达活性。矿化钙结节是成骨细胞分化成熟的标志,同时也是成骨细胞行使成骨功能的主要形态学特征,观察成骨细胞的矿化钙结节是研究成骨细胞分化常用技术之一。Alkaline phosphatase (ALP) is an essential enzyme for bone formation and an early marker of osteogenic differentiation and functional maturation. In order to evaluate the effect of each group of silk fiber substrates on Mc3t3-e1 osteogenic differentiation, alkaline phosphatase staining was used method to determine its expression activity. Mineralized calcium nodules are a sign of osteoblast differentiation and maturity, and are also the main morphological characteristics of osteoblasts performing osteogenic functions. Observing mineralized calcium nodules of osteoblasts is one of the common techniques for studying osteoblast differentiation.

茜素红与碱性磷酸酶染色实验结果如图10所示。通过茜素红与碱性磷酸酶染色实验表明利用聚多巴胺溶液接枝镁离子后表面处理热压蚕丝纤维基拥有优秀的成骨能力。The experimental results of alizarin red and alkaline phosphatase staining are shown in Figure 10. Alizarin red and alkaline phosphatase staining experiments show that the surface treatment of hot-pressed silk fiber base after grafting magnesium ions with polydopamine solution has excellent osteogenic ability.

测试例5动物实验Test Example 5 Animal Experiment

本实施例使用的动物实验为雄性SD大鼠(6~8周龄,体重200±20g),将30只大鼠分为三组,空白对照组、THFSC、TH-PDA@Mg2,每组5只。使用对每只大鼠利用乙醚麻醉,具体方法为:将被乙醚浸湿的消毒脱脂棉球或纱布放入烧杯(1000ml)内,将实验动物放入,用塑料薄膜封口,观察,会发现动物先开始兴奋,继而出现抑制,自行倒下。由于实验时间过长,可将动物固定在实验台上,将含有乙醚的棉球靠近其鼻部,保持吸入状态。起效后颅骨区备皮、消毒、铺巾并使大鼠呈俯卧位,在大鼠颅骨行3cm纵向切口,切开皮肤,皮下组织和肌肉-骨膜层并翻瓣,钝性分离暴露颅骨骨板。用小型牙科钻在颅骨颅中缝制造直径为8mm大小的全层骨膜骨质缺损。空白对照组不放材料,直接用5-0丝线缝合皮下层,消毒后用1#丝线缝合皮肤层。THFSC蚕丝支架组以及PDA@Mg复合蚕丝支架放入材料后再缝合皮肤。术后保温直到大鼠苏醒,分笼饲养,术后每日腹腔注射青霉素20万单位,连续三天。每三天测量大鼠体重,观察大鼠的健康状况。The animal experiments used in this example were male SD rats (6 to 8 weeks old, weight 200±20g). 30 rats were divided into three groups, blank control group, THFSC, TH-PDA@Mg2, each group had 5 rats. Only. Anesthetize each rat with ether. The specific method is as follows: put sterilized absorbent cotton balls or gauze soaked in ether into a beaker (1000ml), put the experimental animal in, seal it with a plastic film, observe, you will find that the animal first Begins to be excited, then becomes inhibited and collapses on his own. Since the experiment time is too long, the animal can be fixed on the experimental table, and the cotton ball containing ether is placed close to its nose to maintain the inhalation state. After the onset of effect, the skull area was skinned, disinfected, draped, and the rat placed in a prone position. A 3cm longitudinal incision was made on the skull of the rat. The skin, subcutaneous tissue, and muscle-periosteal layer were incised and flapped. Blunt dissection was performed to expose the skull bones. plate. A small dental drill was used to create a full-thickness periosteal bone defect with a diameter of 8 mm in the midcranial suture of the skull. In the blank control group, no material was placed, and the subcutaneous layer was sutured directly with 5-0 silk thread. After disinfection, the skin layer was sutured with 1# silk thread. The THFSC silk scaffold group and PDA@Mg composite silk scaffold were put into the material and then the skin was sutured. After surgery, the rats were kept warm until they woke up and were raised in separate cages. After surgery, 200,000 units of penicillin were injected intraperitoneally every day for three consecutive days. The weight of the rats was measured every three days and the health status of the rats was observed.

于术后6周对大鼠进行吸入过量乙醚气体麻醉(方式同上),再给予动物辅助断颈处理。取出大鼠颅骨,置于4%多聚甲醛溶液中固定保存。用Micro-CT对颅骨进行扫描分析。所得Micro-CT三维重建图像结果如图11所示,由图11可以看出,植入支架材料6周后,THFSC和TH-PDA@Mg2处理组缺损边缘都观察到了新骨的生成,且TH-PDA@Mg2处理组生成的新骨更多,而Control组则几乎观察不到新骨的生成。Six weeks after the operation, the rats were anesthetized by inhaling excessive ether gas (the same method as above), and then the animals were given auxiliary neck dissection. The rat skull was removed and fixed and preserved in 4% paraformaldehyde solution. Skull scans were analyzed using Micro-CT. The obtained Micro-CT three-dimensional reconstructed image results are shown in Figure 11. It can be seen from Figure 11 that 6 weeks after implanting the scaffold material, new bone formation was observed at the edge of the defect in both the THFSC and TH-PDA@Mg2 treatment groups, and TH -The PDA@Mg2 treatment group produced more new bone, while the Control group produced almost no new bone.

同时对术后6周骨体积分数(BV/TV)定量,所得定量结果如图12所示,结果显示,TH-PDA@Mg2(12.17±1.06%)相比THFSC(9.43±0.92%)和Control(7.58±1.15%),有更多的矿化基质骨生成。这表明TH-PDA@Mg2组对骨修复的效果更优,修复效果更好。At the same time, the bone volume fraction (BV/TV) was quantified 6 weeks after surgery. The quantitative results are shown in Figure 12. The results showed that TH-PDA@Mg2 (12.17±1.06%) was compared with THFSC (9.43±0.92%) and Control. (7.58±1.15%), there was more mineralized matrix bone formation. This shows that the TH-PDA@Mg2 group has better bone repair effect and better repair effect.

以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above are only preferred embodiments of the present invention. It should be noted that those skilled in the art can make several improvements and modifications without departing from the principles of the present invention. These improvements and modifications can also be made. should be regarded as the protection scope of the present invention.

Claims (10)

1. A preparation method of a polydopamine and magnesium ion modified silk scaffold material comprises the following steps:
(1) Carrying out hot pressing on the stacked multi-layer flat silk to obtain a hot-pressed silk fiber base material;
(2) Soaking the hot-pressed silk fiber substrate in a ternary solution, taking out, and freeze-drying to obtain a pretreated silk fiber substrate; the ternary solution comprises CaCl 2 Ethanol and water;
(3) And soaking the pretreated silk fiber base material in a polydopamine solution containing magnesium ions for modification to obtain the polydopamine and magnesium ion modified silk scaffold material.
2. The method of claim 1, wherein the multilayer flat wire has a stack thickness of 0.1 to 30cm;
the hot pressing temperature is 80-130 ℃, the hot pressing pressure is 10-500 MPa, and the heat preservation and pressure maintaining time is 5-180 min.
3. The method of claim 1, wherein CaCl is present in the ternary solution 2 The mol ratio of ethanol to water is 0.9-1:2:6.5-8.
4. A method according to claim 1 or 3, wherein the soaking temperature in step (2) is 60 to 100 ℃ for 5 to 15 minutes.
5. The preparation method according to claim 1, wherein the preparation method of the polydopamine solution containing magnesium ions comprises the following steps:
mixing dopamine hydrochloride with Tris-HCl solution, and performing self-polymerization reaction to obtain polydopamine solution;
and mixing the soluble magnesium salt with the polydopamine solution to obtain the polydopamine solution containing magnesium ions.
6. The method according to claim 5, wherein the Tris-HCl solution has a concentration of 10mM and a pH of 8.5.
7. The method according to claim 1 or 5, wherein the concentration of magnesium ions in the polydopamine solution is 0.00005 to 0.01mol/L and the concentration of polydopamine is 2 to 4mg/mL.
8. The method according to claim 1, wherein the modification time in the step (3) is 12 to 24 hours.
9. The polydopamine and magnesium ion modified silk scaffold material prepared by the preparation method according to any one of claims 1-8, which comprises a hot-pressed silk fiber substrate and polydopamine and magnesium ions modified on the surface of the silk fiber substrate.
10. Use of polydopamine and magnesium ion modified silk scaffold material according to claim 9 for the preparation of bone repair material.
CN202310897050.3A 2023-07-20 2023-07-20 Polydopamine and magnesium ion modified silk scaffold material and preparation method and application thereof Pending CN116850346A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310897050.3A CN116850346A (en) 2023-07-20 2023-07-20 Polydopamine and magnesium ion modified silk scaffold material and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310897050.3A CN116850346A (en) 2023-07-20 2023-07-20 Polydopamine and magnesium ion modified silk scaffold material and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN116850346A true CN116850346A (en) 2023-10-10

Family

ID=88221378

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310897050.3A Pending CN116850346A (en) 2023-07-20 2023-07-20 Polydopamine and magnesium ion modified silk scaffold material and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN116850346A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102000362A (en) * 2010-12-02 2011-04-06 上海纳米技术及应用国家工程研究中心有限公司 Silk fibroin/nano hydroxyapatite porous bracket material and preparation method thereof
CN114032691A (en) * 2021-11-12 2022-02-11 西南大学 A kind of flat silk antibacterial composite material and preparation method thereof
CN115089765A (en) * 2022-07-15 2022-09-23 西南大学 A kind of flat silk/polylactic acid composite porous bone repair scaffold and preparation method thereof
CN116059442A (en) * 2022-12-13 2023-05-05 慧迈材料科技(广东)有限公司 Repairing material with polyether-ether-ketone as matrix and preparation method and application thereof
WO2023082413A1 (en) * 2021-11-15 2023-05-19 中国科学院深圳先进技术研究院 Injectable metal peroxide compounded hydrogel, and preparation method therefor and use thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102000362A (en) * 2010-12-02 2011-04-06 上海纳米技术及应用国家工程研究中心有限公司 Silk fibroin/nano hydroxyapatite porous bracket material and preparation method thereof
CN114032691A (en) * 2021-11-12 2022-02-11 西南大学 A kind of flat silk antibacterial composite material and preparation method thereof
WO2023082413A1 (en) * 2021-11-15 2023-05-19 中国科学院深圳先进技术研究院 Injectable metal peroxide compounded hydrogel, and preparation method therefor and use thereof
CN115089765A (en) * 2022-07-15 2022-09-23 西南大学 A kind of flat silk/polylactic acid composite porous bone repair scaffold and preparation method thereof
CN116059442A (en) * 2022-12-13 2023-05-05 慧迈材料科技(广东)有限公司 Repairing material with polyether-ether-ketone as matrix and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘毅: "《脂肪移植的基础与临床》", 31 May 2009, 军事医学科学出版社, pages: 168 *

Similar Documents

Publication Publication Date Title
Zheng et al. A review of recent progress on collagen‐based biomaterials
Shen et al. Engineering a highly biomimetic chitosan-based cartilage scaffold by using short fibers and a cartilage-decellularized matrix
Andrée et al. Small intestinal submucosa segments as matrix for tissue engineering
Wang et al. Regenerative porcine dermal collagen matrix developed by supercritical carbon dioxide extraction technology: Role in accelerated wound healing
Lee et al. Development of artificial dermis using 3D electrospun silk fibroin nanofiber matrix
Xue et al. Co‐electrospun silk fibroin and gelatin methacryloyl sheet seeded with mesenchymal stem cells for tendon regeneration
Yu et al. Modification of collagen for biomedical applications: a review of physical and chemical methods
US20080268019A1 (en) Biohybrid elastomeric scaffolds and methods of use thereof
Meng et al. Recent advances of electrospun nanofiber-enhanced hydrogel composite scaffolds in tissue engineering
MX2012008215A (en) Bioengineered tissue constructs and methods for producing and using thereof.
Suchý et al. The effects of different cross-linking conditions on collagen-based nanocomposite scaffolds—an in vitro evaluation using mesenchymal stem cells
CN104888273B (en) A kind of double-layer composite endocranium and preparation method thereof
Olyveira et al. Human dental pulp stem cell behavior using natural nanotolith/bacterial cellulose scaffolds for regenerative medicine
Guan et al. Promoted dermis healing from full-thickness skin defect by porous silk fibroin scaffolds (PSFSs)
Safi et al. Preparing polycaprolactone scaffolds using electrospinning technique for construction of artificial periodontal ligament tissue
Li et al. Tough and VEGF-releasing scaffolds composed of artificial silk fibroin mats and a natural acellular matrix
Jelodari et al. Decellularization of small intestinal submucosa
CN110882416A (en) A kind of preparation method and application of biomimetic composite nanofiber scaffold material
CN115089765A (en) A kind of flat silk/polylactic acid composite porous bone repair scaffold and preparation method thereof
Ghanbari et al. A review of recent advances on osteogenic applications of Silk fibroin as a potential bio-scaffold in bone tissue engineering
CN116850346A (en) Polydopamine and magnesium ion modified silk scaffold material and preparation method and application thereof
CN112295021A (en) A skin graft with improved topology
CN101204592A (en) Preparation technology of biomimetic tissue engineering esophagus
CN108096634B (en) A kind of artificial bone graft's material and application thereof
Lin et al. Surface modification of poly (ε‐caprolactone) porous scaffolds using gelatin hydrogel as the tracheal replacement

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination